Found: 5
Select item for more details and to access through your institution.
Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals.
- Published in:
- Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-48
- By:
- Publication type:
- Article
Optimizing the Clinical Use of the GLP-1 Receptor Agonist Exenatide Once Weekly.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Optimizing the Clinical Use of the GLP-1 Receptor Agonist Exenatide Once Weekly.
- Published in:
- Diabetes Spectrum, 2013, v. 26, n. 1, p. 46, doi. 10.2337/diaspect.26.1.46
- By:
- Publication type:
- Article
Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Once-Weekly Glucose-Lowering Therapy for Type 2 Diabetes.
- Published in:
- Clinical Diabetes, 2012, v. 30, n. 3, p. 95, doi. 10.2337/diaclin.30.3.95
- By:
- Publication type:
- Article